Rhumbline Advisers Iradimed Corp Transaction History

Rhumbline Advisers

$104 Billion
Q1 2025

A detailed history of Rhumbline Advisers transactions in Iradimed Corp stock. As of the latest transaction made, Rhumbline Advisers holds 13,703 shares of IRMD stock, worth $718,174. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,703

Previous 19,252 28.82%

Holding current value

$718,174

Previous $1.06 Million 32.14%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 08, 2025	SELL	$51.44 - $62.67 $285,440 - $347,755	-5,549 Reduced 28.82%	13,703 $718,000
Q4 2024 Jan 30, 2025	BUY	$48.3 - $57.35 $292,794 - $347,655	6,062 Added 45.96%	19,252 $1.06 Million
Q3 2024 Nov 12, 2024	BUY	$43.23 - $50.29 $96,013 - $111,694	2,221 Added 20.25%	13,190 $663,000
Q2 2024 Aug 01, 2024	BUY	$40.36 - $44.7 $45,687 - $50,600	1,132 Added 11.51%	10,969 $481,000
Q1 2024 May 09, 2024	BUY	$41.17 - $47.29 $13,133 - $15,085	319 Added 3.35%	9,837 $432,000
Q4 2023 Feb 08, 2024	SELL	$37.31 - $47.47 $3,245 - $4,129	-87 Reduced 0.91%	9,518 $451,000
Q3 2023 Nov 09, 2023	BUY	$43.28 - $50.3 $16,662 - $19,365	385 Added 4.18%	9,605 $426,000
Q2 2023 Aug 08, 2023	SELL	$38.88 - $50.61 $5,248 - $6,832	-135 Reduced 1.44%	9,220 $440,000
Q1 2023 May 11, 2023	BUY	$28.48 - $42.14 $5,809 - $8,596	204 Added 2.23%	9,355 $368,000
Q4 2022 Feb 14, 2023	BUY	$26.9 - $30.58 $7,801 - $8,868	290 Added 3.27%	9,151 $259,000
Q3 2022 Nov 10, 2022	BUY	$29.42 - $42.25 $16,828 - $24,167	572 Added 6.9%	8,861 $266,000
Q2 2022 Aug 11, 2022	BUY	$30.15 - $45.79 $71,274 - $108,247	2,364 Added 39.9%	8,289 $281,000
Q1 2022 May 12, 2022	BUY	$36.01 - $53.14 $26,899 - $39,695	747 Added 14.43%	5,925 $266,000
Q4 2021 Feb 10, 2022	BUY	$32.35 - $48.27 $167,508 - $249,942	5,178 New	5,178 $239,000

Others Institutions Holding IRMD

# of Institutions

169

Shares Held

6.8M

Call Options Held

600

Put Options Held

900

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $659M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Iradimed Corp Transaction History